2018-001124-20: Efficacy of Olaratumab and Re-Treatment with Doxorubicin in anthracycline pretreated, advanced soft tissue sarcoma patients. |
|
|
| Ongoing | 2 | 60 | Europe | Dexrazoxan, Doxorubicinhydrochlorid, Concentrate for solution for infusion, Powder for solution for infusion, Lartruvo®, CARDIOXANE® | IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest, Lilly Deutschland GmbH, Clinigen Healthcare Limited | locally advanced (unresectable) or metastatic soft tissue sarcoma, locally advanced (unresectable) or metastatic soft tissue sarcoma, Diseases [C] - Cancer [C04] | | | | |
